vs

Side-by-side financial comparison of Merck & Co. (MRK) and Visa Inc. (V). Click either name above to swap in a different company.

Merck & Co. is the larger business by last-quarter revenue ($16.3B vs $11.2B, roughly 1.5× Visa Inc.). Visa Inc. runs the higher net margin — 53.4% vs 0.9%, a 52.6% gap on every dollar of revenue. On growth, Visa Inc. posted the faster year-over-year revenue change (17.0% vs 4.9%). Over the past eight quarters, Visa Inc.'s revenue compounded faster (8.1% CAGR vs 0.5%).

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.

Visa Inc. is an American multinational payment card services corporation headquartered in San Francisco, California. It facilitates electronic funds transfers throughout the world, most commonly through Visa-branded credit cards, debit cards and prepaid cards.

MRK vs V — Head-to-Head

Bigger by revenue
MRK
MRK
1.5× larger
MRK
$16.3B
$11.2B
V
Growing faster (revenue YoY)
V
V
+12.1% gap
V
17.0%
4.9%
MRK
Higher net margin
V
V
52.6% more per $
V
53.4%
0.9%
MRK
Faster 2-yr revenue CAGR
V
V
Annualised
V
8.1%
0.5%
MRK

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
MRK
MRK
V
V
Revenue
$16.3B
$11.2B
Net Profit
$141.0M
$6.0B
Gross Margin
74.2%
Operating Margin
64.4%
Net Margin
0.9%
53.4%
Revenue YoY
4.9%
17.0%
Net Profit YoY
-9.5%
32.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRK
MRK
V
V
Q2 26
$11.2B
Q1 26
$16.3B
Q4 25
$16.4B
$10.9B
Q3 25
$17.3B
$10.7B
Q2 25
$15.8B
$10.2B
Q1 25
$15.5B
$9.6B
Q4 24
$15.6B
$9.5B
Q3 24
$16.7B
$9.6B
Net Profit
MRK
MRK
V
V
Q2 26
$6.0B
Q1 26
$141.0M
Q4 25
$3.0B
$5.9B
Q3 25
$5.8B
$5.1B
Q2 25
$4.4B
$5.3B
Q1 25
$5.1B
$4.6B
Q4 24
$3.7B
$5.1B
Q3 24
$3.2B
$5.3B
Gross Margin
MRK
MRK
V
V
Q2 26
Q1 26
74.2%
Q4 25
66.2%
Q3 25
77.7%
Q2 25
77.5%
Q1 25
78.0%
Q4 24
75.5%
Q3 24
75.5%
Operating Margin
MRK
MRK
V
V
Q2 26
64.4%
Q1 26
Q4 25
20.9%
61.8%
Q3 25
39.0%
57.3%
Q2 25
31.6%
60.7%
Q1 25
38.0%
56.6%
Q4 24
26.7%
65.6%
Q3 24
24.6%
66.0%
Net Margin
MRK
MRK
V
V
Q2 26
53.4%
Q1 26
0.9%
Q4 25
18.1%
53.7%
Q3 25
33.5%
47.5%
Q2 25
28.0%
51.8%
Q1 25
32.7%
47.7%
Q4 24
24.0%
53.8%
Q3 24
19.0%
55.3%
EPS (diluted)
MRK
MRK
V
V
Q2 26
Q1 26
Q4 25
$1.19
Q3 25
$2.32
Q2 25
$1.76
Q1 25
$2.01
Q4 24
$1.49
Q3 24
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRK
MRK
V
V
Cash + ST InvestmentsLiquidity on hand
$12.4B
Total DebtLower is stronger
$22.4B
Stockholders' EquityBook value
$35.7B
Total Assets
$95.0B
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRK
MRK
V
V
Q2 26
$12.4B
Q1 26
Q4 25
$14.6B
$14.8B
Q3 25
$18.2B
$17.2B
Q2 25
$8.6B
$17.1B
Q1 25
$9.2B
$11.7B
Q4 24
$13.7B
$12.4B
Q3 24
$14.6B
$12.0B
Total Debt
MRK
MRK
V
V
Q2 26
$22.4B
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Stockholders' Equity
MRK
MRK
V
V
Q2 26
$35.7B
Q1 26
Q4 25
$52.6B
$38.8B
Q3 25
$51.9B
$37.9B
Q2 25
$49.0B
$38.7B
Q1 25
$48.3B
$38.0B
Q4 24
$46.3B
$38.3B
Q3 24
$44.5B
$39.1B
Total Assets
MRK
MRK
V
V
Q2 26
$95.0B
Q1 26
Q4 25
$136.9B
$96.8B
Q3 25
$129.5B
$99.6B
Q2 25
$117.5B
$100.0B
Q1 25
$115.1B
$92.9B
Q4 24
$117.1B
$91.9B
Q3 24
$117.5B
$94.5B
Debt / Equity
MRK
MRK
V
V
Q2 26
0.63×
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRK
MRK

Segment breakdown not available.

V
V

Data processing revenue$5.5B49%
International transaction revenue$3.6B32%
Other revenue$1.3B12%
Other$736.0M7%

Related Comparisons